Life Science Healthcare Research


We provide customized research solutions to life sciences and healthcare clients to help them understand the market and competitive landscape, improve efficiencies and productivity, conduct pipeline analysis, assess therapeutic areas and formulate effective developmental and commercial strategies.

Our engagements are with large and mid-tier pharmaceutical, biotechnology, medical devices and consumer health companies and healthcare consulting firms operating across the globe. We offer flexible, scaleable, and cost-effective strategic research solutions across key domains, covering a wide spectrum of therapeutic areas.

Our clients have gained tangible business value through our unparalleled domain expertise, customised research offerings and effective execution capabilities.

How we are different

Broad spectrum of service offerings supporting a number of functions within pharma, bio-pharma and medical device companies

Long term partnerships to drive efficiency in client operations

Ability to scale up or down based on requirements, both current and future

International delivery centers available to provide round the clock support with multi-lingual capabilities

Structured governance process and high data security through sustained investment from Acuity Knowledge Partners

Integrating data analytics’ capabilities with domain experts providing insights analyzing large unstructured data

What we have done

Product launch strategy for European biopharmaceutical company
What we are proud of

Identified geographical concentration of demand

Designed optimal distribution channel configuration

Opportunity assessment and market attractiveness for one of the top 10 pharmaceutical major
What we are proud of

Benchmarked therapeutic areas with high clinical and market potential

Developed potential market scenarios based on client needs

Competitor benchmarking and performance gap analysis for a leading European medical device player
What we are proud of

Identified opportunities for expansion and plausible revenue streams

Identified potential geographies and activation levers from competitors

Assessing viability of entering the NSCLC market
What we are proud of

Evaluated unmet needs to identify potential entry points

Conducted a deep-dive study of key assets and key players

Assessment of GCC pharmaceutical market for a global European pharma major
What we are proud of

Analysed potential for entry into the GCC pharmaceutical market

Assessed possible market drivers and barriers to entry

Supplier assessment and industry benchmarking for a global top 10 pharmaceutical company
What we are proud of

Optimised vendor-associated costs across geographies

Identified billing arrangements across law firms

Research on a multiple sclerosis drug with help from global neurologists
What we are proud of

Assessed the target market size, key competitors and current pricing range

Enabled the client to take informed decisions thereby increasing market penetration

Procurement in non-Food FMCG Industry
What we are proud of


sourcing cost reductions by

Macro-economics/ regulation

Our perspective on Life Science Healthcare Research
The pharma space after COVID-19 vaccine rollouts, market dynamics and the path of consolidation and fund raising Blog
The pharma space after COVID-19 vaccine rollouts, market dynamics and the path of consolidation and fund raising

The public, media, exper..... Read More

What makes an oncology molecule generate USD100m in the first year? Insights
What makes an oncology molecule generate USD100m in the first year?

......... Read More

March 17, 2021

Approach , biopharma , cancer

Corporate wellness trends 2021 Blog
Corporate wellness trends 2021

Healthy employee..... Read More

March 3, 2021

Business , COVID19 , Health

Thank you for sharing your details

Share this on